Publicaciones en colaboración con investigadores/as de University of Pennsylvania (40)

2024

  1. Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry

    Journal of Cardiac Failure

  2. Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM

    Journal of the American Heart Association, Vol. 13, Núm. 15, pp. e035993

  3. Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4

    Journal of Cardiac Failure

  4. Evolution and advancements in genomics and epigenomics in OA research: How far we have come

    Osteoarthritis and Cartilage

  5. Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM

    Journal of the American College of Cardiology, Vol. 84, Núm. 19, pp. 1821-1831

  6. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

  7. Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM

    Journal of the American College of Cardiology, Vol. 84, Núm. 19, pp. 1839-1849

2023

  1. Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 81, Núm. 1, pp. 34-45

  2. Structure-function-guided design of synthetic peptides with anti-infective activity derived from wasp venom

    Cell Reports Physical Science, Vol. 4, Núm. 7

  3. Three decades of advancements in osteoarthritis research: insights from transcriptomic, proteomic, and metabolomic studies

    Osteoarthritis and Cartilage

2022

  1. Antimicrobial Peptides: Potential Therapeutics Against Drug-Resistant Pulmonary Infections

    Archivos de Bronconeumologia

  2. Biologically Active Peptides from Venoms: Applications in Antibiotic Resistance, Cancer, and Beyond

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

2021

  1. Author Correction: Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications (Scientific Reports, (2021), 11, 1, (1526), 10.1038/s41598-021-81093-y)

    Scientific Reports

  2. Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications

    Scientific Reports, Vol. 11, Núm. 1

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus

    Circulation: Genomic and Precision Medicine, Vol. 13, Núm. 6, pp. E002769

  2. Light-Emitting Probes for Labeling Peptides

    Cell Reports Physical Science, Vol. 1, Núm. 12

  3. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet, Vol. 396, Núm. 10253, pp. 759-769

  4. Micelle-directed chiral seeded growth on anisotropic gold nanocrystals

    Science (New York, N.Y.), Vol. 368, Núm. 6498, pp. 1472-1477

2019

  1. Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors

    Nature Genetics, Vol. 51, Núm. 5, pp. 804-814